missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Epredia™ Lab Vision™ Prostate Specific Membrane Antigen (PSMA) Rabbit Monoclonal Antibody, supernatant
Employ part of a comprehensive antibody portfolio with the Epredia™ Prostate Specific Membrane Antigen, Rabbit Monoclonal Antibody. Studies show rabbit monoclonal antibodies are more sensitive and specific than other available markers.
210.12€ - 1170.00€
Especificaciones
| Antígeno | Prostate Specific Membrane Antigen (PMSA) |
|---|---|
| Clon | SP29 |
| Aplicaciones | Immunohistochemistry (Paraffin) |
| Clasificación | Monoclonal |
| Conjugado | Unconjugated |
| Código de producto | Marca | Formulario | Cantidad | Precio | Cantidad y disponibilidad | ||||
|---|---|---|---|---|---|---|---|---|---|
| Código de producto | Marca | Formulario | Cantidad | Precio | Cantidad y disponibilidad | ||||
|
12633797
|
Epredia™
RM-9131-S0 |
Concentrated | 100 μL |
Este artículo actualmente no está disponible o ha sido discontinuado. Ver la página del producto para posibles alternativas |
|||||
|
12613797
|
Epredia™
RM-9131-S |
Concentrated | 1 mL |
Este artículo actualmente no está disponible o ha sido discontinuado. Ver la página del producto para posibles alternativas |
|||||
|
12683787
|
Epredia™
RM-9131-R7 |
Prediluted | 7 mL |
Este artículo actualmente no está disponible o ha sido discontinuado. Ver la página del producto para posibles alternativas |
|||||
|
12693787
|
Epredia™
RM-9131-RQ |
Ready-to-Use | 12 mL |
Este artículo actualmente no está disponible o ha sido discontinuado. Ver la página del producto para posibles alternativas |
|||||
Descripción
Prostate Specific Membrane Antigen (PSMA) is a surface glycoprotein with restricted expression to normal prostate tissue, primary and metastatic prostate cancer and the neovasculature of various nonprostatic epithelial malignancies. Overexpression of PSMA is correlated with high tumor grade, non-diploid tumors, and advanced tumor stage. Even though PSA is useful in identifying the prostate origin of cancers, PSMA shows moderate to strong positivity in one-half of the cells per case that show relatively poor PSA staining, and is excellent in differentiating between prostatic adenocarcinoma and urothelial carcinoma. PSMA is expressed in 94.3% to 100% of primary and 57.7% to 100% of metastatic prostatic carcinomas. PSMA is recognized as a viable target for cancer therapy.
Host Species: Rabbit
Clone: SP29
Species Reactivity: Human. Others not known.
Immunogen: C-terminal
Molecular Weight: 84kDa
Positive Control: Prostate carcinoma
Cellular Localization: Cytoplasmic and membrane
Recommended for:
- Immunohistochemistry (Formalin/paraffin)
Especificaciones
| Prostate Specific Membrane Antigen (PMSA) | |
| Immunohistochemistry (Paraffin) | |
| Unconjugated | |
| IVD | |
| C-terminal |
| SP29 | |
| Monoclonal | |
| Rabbit | |
| Cancer and Tumor Biology | |
| Primary |